2021 Nonalcoholic Fatty Liver Disease SIG: Precision Medicine in Evaluation and Treatment of NAFLD
Recorded On: 11/11/2021
Already registered?
Sign in now.
Precision medicine in NAFLD may be within reach due to exciting advances in AI technology and genomics. At this years NAFLD SIG program, renowned experts share new insights on precision medicine for NAFLD, including recent trends and developments in NAFLD genomics and transcriptomics, and advances in artificial intelligence for NAFLD diagnosis.
Complete
Next
Failed
Available
Locked